(Q53598442)

16 May 2018

title

Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. (English)

1 reference

16 May 2018

main subject

TNF

0 references

inflammation

0 references

transmembrane protein

0 references

author

Lena Alexopoulou

1

1 reference

16 May 2018

Anastasia Kotanidou

5

1 reference

16 May 2018

Giorgos Kollias

9

1 reference

16 May 2018

Perry J. Blackshear

object named as

Perry J Blackshear

7

0 references

author name string

Ksanthi Kranidioti

2

1 reference

16 May 2018

Sofia Xanthoulea

3

1 reference

16 May 2018

Maria Denis

4

1 reference

16 May 2018

Eleni Douni

6

1 reference

16 May 2018

Dimitris L Kontoyiannis

8

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

16 May 2018

European Journal of Immunology

published in

1 reference

16 May 2018

volume

36

1 reference

16 May 2018

page(s)

2768-2780

1 reference

16 May 2018

issue

10

1 reference

16 May 2018

Membrane protein secretases

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

Membrane tumor necrosis factor confers partial protection to Listeria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Two tumour necrosis factor receptors: structure and function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor receptor and Fas signaling mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200635921

1 reference

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Structural features and biochemical properties of TNF-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Pneumocystis carinii pneumonia following a second infusion of infliximab

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor biology in experimental and clinical arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Mixed haplotypes and autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Membrane TNF confers protection to acute mycobacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Defective CD4T cell priming and resistance to experimental autoimmune encephalomyelitis in TNF-deficient mice due to innate immune hypo-responsiveness

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Anti-cytokine therapeutics and infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Induction of unresponsiveness to tumor necrosis factor (TNF) after autocrine TNF expression requires TNF membrane retention.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Development and maturation of secondary lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment o

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A role for the phagosome in cytokine secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Identifiers

DOI

10.1002/EJI.200635921

1 reference

16 May 2018

PubMed ID

16983719

1 reference

16 May 2018